LifeMD

Ticker: LFMD

Sector: Pharmaceutical Retailers

LifeMD

David Harlow speaks with Payel Gupta, MD, medical director of Cleared, powered by LifeMD, about the evolution of allergies and of telemedicine for allergy care. Harlow on healthcare: payel gupta md, medical. director of cleared, powered. by lifemd. LifeMD Inc. stock has received a consensus rating of buy. The 11 analysts offering price forecasts for LifeMD stock have a median target of 8.82, with a high estimate of 12.00 and a low estimate of 7.00. LifeMD is 64.22% away from the 52-week high. LifeMD: Embrace your journey towards a healthier, happier you, and achieve lasting, sustainable weight loss with LifeMD by your side. Visit lifemd.com/VELVET to start your Weight Loss Journey Today. LifeMD, Inc. Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA Revenue increased 23% year-over-year to $38.6 million with both telehealth and WorkSimpli achieving record revenues. LifeMD expects a 38% increase in revenues for 2024 driven by its new telehealth operation for GLP-1 obesity drugs. LifeMD reached 16,000 subscribers by the end of the third quarter of 2023 which is an annual revenue rate of $24 million. LifeMD stock was recently punished by the market for Eli Lillys decision to direct sell its obesity drugs. Based on the comparables, and factoring in WorkSimpli, I believe LifeMD should be trading at 2x revenues.